Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Olmedo ME"'
Autor:
Paz-Ares, L, Ciuleanu, T, Navarro, A, Fulop, A, Cousin, S, Bonanno, L, Smit, E, Chiappori, A, Olmedo, ME, Horvath, I, Grohe, C, Lopez-Vilarino, JA, Nunez, R, Nieto, A, Cullell, M, Vasco, N, Kahatt, C, Zeaiter, A, Carcereny, E, Roubec, J, Syrigos, K, Lo, G, Barneto, I
Publikováno v:
Journal of Thoracic Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3587af1f2f0ef80975068160558370e9
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3655
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3655
Autor:
J.A. Lopez-Vilariño, Victor Moreno, Rafael Nuñez, Michael Flynn, Carmen Kahatt, Martin Forster, Irene Brana, Maria Eugenia Olmedo, Bernard Doger, Ali Zeaiter, Maria de Miguel, Emiliano Calvo, Martin Cullell-Young, María Pilar López-Criado
Publikováno v:
Investigational New Drugs
Scientia
Scientia
SummaryBackground A phase I study found remarkable activity and manageable toxicity for doxorubicin (bolus) plus lurbinectedin (1-h intravenous [i.v.] infusion) on Day 1 every three weeks (q3wk) as second-line therapy in relapsed small cell lung canc
Autor:
Dowlati A; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH., Hummel HD; Translational Oncology/Early Clinical Trial Unit (ECTU), Bavarian Cancer Research Center, National Center for Tumor Diseases, Comprehensive Cancer Center Mainfranken and University Hospital Würzburg, Würzburg, Germany., Champiat S; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, Villejuif, France., Olmedo ME; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain., Boyer M; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia.; Faculty of Medicine and Health, School of Medicine, University of Sydney, Sydney, Australia., He K; Comprehensive Cancer Center, Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Izumi H; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Johnson ML; Department of Medical Oncology, Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN., Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Bouchaab H; Department of Oncology, Vaud University Hospital, Lausanne, Switzerland., Borghaei H; Fox Chase Cancer Center, Philadelphia, PA., Felip E; Department of Medical Oncology, Hospital Universitario del Vall d'Hebron, Barcelona, Spain., Jost PJ; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Gadgeel S; Division of Hematology and Oncology, Department of Internal Medicine, Henry Ford Cancer Institute/Henry Ford Health System, Detroit, MI., Chen X; Amgen Inc, Thousand Oaks, CA., Yu Y; Amgen Inc, Thousand Oaks, CA., Martinez P; Amgen Inc, Thousand Oaks, CA., Parkes A; Amgen Inc, Thousand Oaks, CA., Paz-Ares L; Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Complutense University and Ciberonc, Madrid, Spain.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 10; Vol. 42 (29), pp. 3392-3399. Date of Electronic Publication: 2024 Aug 29.
Autor:
Albarrán V; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. vicalbarranfernandez@gmail.com., Guerrero P; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., de Quevedo CG; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., González C; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Chamorro J; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Rosero DI; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Moreno J; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Calvo JC; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., de Aguado PP; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Alía V; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Sotoca P; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Barrill AM; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Román MS; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Álvarez-Ballesteros P; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Serrano JJ; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Soria A; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Olmedo ME; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Saavedra C; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Cortés A; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Gómez A; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Lage Y; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Ruiz Á; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Ferreiro MR; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Longo F; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Garrido P; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Gajate P; Department of Medical Oncology, Ramon y Cajal University Hospital (Madrid), Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Aug 02; Vol. 73 (10), pp. 186. Date of Electronic Publication: 2024 Aug 02.
Autor:
Aix SP; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Ciuleanu TE; Department of Oncology, Institutul Oncologic Prof Dr Ion Chiricuta, Cluj-Napoca, Romania., Navarro A; Medical Oncology Department, Vall d'Hebron University Hospital & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Cousin S; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Bonanno L; Medical Oncology 2, Istituto Oncologico Veneto, Padova, Italy., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Chiappori A; Department of Thoracic Oncology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Olmedo ME; Hospital Universitario Ramón y Cajal, Madrid, Spain., Horvath I; National Koranyi Institute for Pulmonology, Budapest, Hungary., Grohé C; Department of Respiratory Diseases, Evangelische Lungenklinik Berlin, Berlin, Germany., Farago AF; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Cancer Center, Boston, MA, USA., López-Vilariño JA; PharmaMar, Madrid, Spain., Cullell-Young M; PharmaMar, Madrid, Spain., Nieto A; PharmaMar, Madrid, Spain., Vasco N; PharmaMar, Madrid, Spain., Gómez J; PharmaMar, Madrid, Spain., Kahatt C; PharmaMar, Madrid, Spain., Zeaiter A; PharmaMar, Madrid, Spain., Carcereny E; Badalona-Applied Research Group in Oncology (B-ARGO) and Medical Oncology Department, Catalan Institute of Oncology Badalona, Germans Trias i Pujol Hospital, Barcelona, Spain., Roubec J; Nemocnice AGEL Ostrava-Vítkovice, Ostrava-Vítkovice, Czech Republic., Syrigos K; National and Kapodistrian University of Athens, Athens, Greece., Lo G; R S McLaughlin Durham Regional Cancer Centre, Lakeridge Health, Oshawa, ON, Canada., Barneto I; Hospital Provincial Reina Sofía, Córdoba, Spain., Pope A; Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK., Sánchez A; Hospital Universitario Virgen del Rocío, Seville, Spain., Kattan J; Hotel-Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon., Zarogoulidis K; Aristotle University of Thessaloniki, Thessaloniki, Greece., Waller CF; University Medical Centre Freiburg, Freiburg, Germany., Bischoff H; Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany., Juan-Vidal O; Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain., Reinmuth N; Asklepios Fachkliniken München, Gauting, Germany., Dómine M; Hospital Universitario Fundación Jiménez Diaz, Madrid, Spain., Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain; CNIO-H12o Lung Cancer Clinical Research Unit, Madrid, Spain; Ciberonc, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain. Electronic address: lpazaresr@seom.org.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2023 Jan; Vol. 11 (1), pp. 74-86. Date of Electronic Publication: 2022 Oct 14.
Autor:
Cortés A; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Casado JL; Infectious Disease Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Longo F; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Centro de Investigación Biomédica en Red (CIBERONC), Alcalá de Henares University, Madrid, Spain., Serrano JJ; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Saavedra C; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Velasco H; Laboratory of Immunovirology, Infectious Diseases Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Martin A; Laboratory of Immunovirology, Infectious Diseases Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Chamorro J; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Rosero D; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Fernández M; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Gion M; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Martínez Jáñez N; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Soria Rivas A; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Alonso Gordoa T; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Martínez Delfrade Í; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Lage Y; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., López Miranda E; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Olmedo ME; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Reguera Puertas P; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Gajate P; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Molina Cerrillo J; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Guerra Alia E; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Fuentes Mateos R; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Romero B; Microbiology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Rodríguez-Domínguez MJ; Microbiology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Centro de Investigación Biomédica en Red (CIBER) en Epidemiología y Salud Pública, Spain., Vallejo A; Laboratory of Immunovirology, Infectious Diseases Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. Electronic address: alejandro.vallejo@salud.madrid.org., Carrato A; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Centro de Investigación Biomédica en Red (CIBERONC), Alcalá de Henares University, Madrid, Spain. Electronic address: acarrato@telefonica.net.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 May; Vol. 166, pp. 229-239. Date of Electronic Publication: 2022 Mar 01.
Autor:
Olmedo ME; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid 28034, Spain. maruolmedogarcia@hotmail.com., Cervera R; Department of Medical Oncology, Del Henares University Hospital, Coslada 28822, Madrid, Spain., Cabezon-Gutierrez L; Medical Oncology, Hospital Universitario de Torrejón, Torrejón de Ardoz 28850, Madrid, Spain., Lage Y; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid 28034, Spain., Corral de la Fuente E; Medical Oncology Department, Hospital Universitario Ramon y Cajal, Madrid 28034, Spain., Gómez Rueda A; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid 28034, Spain., Mielgo-Rubio X; Department of Medical Oncology, Foundation Alcorcón University Hospital, Alcorcón 28922, Madrid, Spain., Trujillo JC; Department Thoracic Surgery, Hospital de la Santa Creu I Sant Pau, Barcelona 08029, Catalonia, Spain., Couñago F; Department of Radiation Oncology, Hospital Universitario Quirónsalud Madrid, Pozuelo 28223, Madrid, Spain.
Publikováno v:
World journal of clinical oncology [World J Clin Oncol] 2022 Apr 24; Vol. 13 (4), pp. 276-286.
Autor:
Olmedo ME; Hospital Ramon y Cajal, Madrid, Spain., Forster M; University College of London Hospital and UCL Cancer Institute, London, UK., Moreno V; START Madrid - FJD (Hospital Fundación Jiménez Díaz), Madrid, Spain., López-Criado MP; M.D. Anderson Cancer Center, Madrid, Spain., Braña I; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Flynn M; University College of London Hospital and UCL Cancer Institute, London, UK., Doger B; START Madrid - FJD (Hospital Fundación Jiménez Díaz), Madrid, Spain., de Miguel M; START Madrid - HM CIOCC, Hospital Madrid Norte Sanchinarro, Madrid, Spain., López-Vilariño JA; Pharma Mar, S.A., Colmenar Viejo, Madrid, Spain., Núñez R; Pharma Mar, S.A., Colmenar Viejo, Madrid, Spain., Kahatt C; Pharma Mar, S.A., Colmenar Viejo, Madrid, Spain., Cullell-Young M; Pharma Mar, S.A., Colmenar Viejo, Madrid, Spain., Zeaiter A; Pharma Mar, S.A., Colmenar Viejo, Madrid, Spain., Calvo E; START Madrid - HM CIOCC, Hospital Madrid Norte Sanchinarro, Madrid, Spain. emiliano.calvo@startmadrid.com.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2021 Oct; Vol. 39 (5), pp. 1275-1283. Date of Electronic Publication: 2021 Mar 11.
Autor:
Muñoz-Unceta N; University Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain. Electronic address: nere.mun@gmail.com., Zugazagoitia J; University Hospital 12 de Octubre, Madrid, Spain; Lung Cancer Unit H12O-CNIO, Spain., Manzano A; San Carlos Clinical Hospital, Madrid, Spain., Jiménez-Aguilar E; University Hospital 12 de Octubre, Madrid, Spain., Olmedo ME; University Hospital Ramón y Cajal, Madrid, Spain., Cacho JD; University Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain., Oliveira J; Portuguese Institute of Oncology of Porto, Portugal., Dómine M; University Hospital Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain., Ortega-Morán L; University Hospital Gregorio Marañón, Madrid, Spain., Aguado C; San Carlos Clinical Hospital, Madrid, Spain., Luna AM; Hospital Ruber Internacional, Madrid, Spain., Fernández L; University Hospital Virgen de la Salud, Toledo, Spain., Pérez J; Hospital Virgen de los Lirios, Alcoy, Spain., Font C; Hospital Clinic, Barcelona, Spain., Salvador C; University Hospital la Fé, Valencia, Spain., Corral J; Clínica Universidad de Navarra, Madrid, Spain., Benítez G; Hospital Insular de Gran Canaria, Gran Canaria, Spain., Ros S; Hospital Virgen de la Arrixaca, Murcia, Spain., Biosca M; Hospital Vall d'Hebron, Barcelona, Spain., Calvo V; University Hospital Puerta de Hierro, Majadahonda, Spain., Martínez J; University Hospital Virgen del Rocío, Sevilla, Spain., Sánchez-Cánovas M; Hospital Morales Meseguer, Murcia, Spain., López R; University Hospital Clínico de Valladolid, Valladolid, Spain., Sereno M; University Hospital Infanta Sofía, San Sebastián de los Reyes, Spain., Mielgo X; Hospital Fundación de Alcorcón, Alcorcón, Spain., Aparisi F; University Hospital General de Valencia, Valencia, Spain., Carmona M; Hospital Lucus Augusti, Lugo, Spain., Carrión R; University Hospital del Sureste, Madrid, Spain., Ponce-Aix S; University Hospital 12 de Octubre, Madrid, Spain; Lung Cancer Unit H12O-CNIO, Spain., Soares M; Portuguese Institute of Oncology of Porto, Portugal., Martínez-Salas I; University Hospital Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain., García-Morillo M; Hospital Clinic, Barcelona, Spain., Juan-Vidal O; University Hospital la Fé, Valencia, Spain., Blasco A; University Hospital General de Valencia, Valencia, Spain., Muñoz AJ; University Hospital Gregorio Marañón, Madrid, Spain., Paz-Ares L; University Hospital 12 de Octubre, Madrid, Spain; Lung Cancer Unit H12O-CNIO, Spain; Ciberonc, Spain; University Complutense de Madrid, Spain.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Dec; Vol. 141, pp. 193-198. Date of Electronic Publication: 2020 Nov 07.
Autor:
Subbiah V; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: vsubbiah@mdanderson.org., Paz-Ares L; Hospital Universitario Doce de Octubre, Madrid, Spain., Besse B; Gustave Roussy Cancer Campus, Villejuif, France., Moreno V; START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Peters S; University Hospital CHUV, Lausanne, Switzerland., Sala MA; Hospital Universitario de Basurto, Bilbao, Spain., López-Vilariño JA; PharmaMar, Colmenar Viejo, Spain., Fernández C; PharmaMar, Colmenar Viejo, Spain., Kahatt C; PharmaMar, Colmenar Viejo, Spain., Alfaro V; PharmaMar, Colmenar Viejo, Spain., Siguero M; PharmaMar, Colmenar Viejo, Spain., Zeaiter A; PharmaMar, Colmenar Viejo, Spain., Zaman K; University Hospital CHUV, Lausanne, Switzerland., López R; Hospital Clínico Universitario de Santiago de Compostela, Santiago De Compostela, Spain., Ponce S; Hospital Universitario Doce de Octubre, Madrid, Spain., Boni V; START Madrid-CIOCC, Hospital Universitario Sanchinarro, Madrid, Spain., Arrondeau J; Hôpital Cochin, Paris, France., Delord JP; Institut Claudius Regaud, Toulouse, France., Martínez M; Complejo Hospitalario de Navarra, Pamplona, Spain., Wannesson L; Ospedale San Giovanni, Bellinzona, Switzerland., Antón A; Hospital Universitario Miguel Servet, Zaragoza, Spain., Valdivia J; Hospital Universitario Virgen de las Nieves, Granada, Spain., Awada A; Institut Jules Bordet, Université Libre De Bruxelles, Brussels, Belgium., Kristeleit R; UCL Cancer Institute, London, United Kingdom., Olmedo ME; Hospital Universitario Ramón y Cajal, Madrid, Spain., Rubio MJ; Hospital Universitario Reina Sofía, Cordoba, Spain., Sarantopoulos J; Institute for Drug Development, Mays Cancer Center at University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USA., Chawla SP; Sarcoma Oncology Center, Santa Monica, CA, USA., Mosquera-Martinez J; Complexo Hospitalario Universitario A Coruña, A Coruña, Spain., D' Arcangelo M; Ospedale Santa Maria delle Croci, Ravenna, Italy., Santoro A; Istituto Clinico Humanitas, Rossano, Italy., Villalobos VM; University of Colorado Cancer Center, Aurora, USA., Sands J; Dana-Farber Cancer Institute, Boston, MA, USA., Trigo J; Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2020 Dec; Vol. 150, pp. 90-96. Date of Electronic Publication: 2020 Oct 10.